Carlyle Group Inc. INFORMATION TABLE, Q2 FY2021

SEC Form 13F Summary: Carlyle Group Inc.

Business Context and Reporting Period

This filing is a Form 13F Information Table submitted by Carlyle Group Inc. for the reporting period ending June 30, 2021. The document discloses the investment manager's holdings in equity securities as of the close of the quarter.

Key Financial Metrics and Holdings

The filing details specific equity positions held by the manager. The total value of the disclosed holdings in this table is approximately $476.3 million. The portfolio consists of 11 distinct issuers. Voting authority is reported as "Sole" for all listed positions.

Issuer Shares Held Value ($) Voting Authority
Ortho Clinical Diagnostics H 3,070,322 143,406,000 Sole
Atotech Ltd (Position 2) 2,395,764 93,841,130 Sole
ZoomInfo Technologies Inc 4,606,375 88,295,467 Sole
Atotech Ltd (Position 1) 1,527,500 59,831,573 Sole
PPD Inc 2,568,261 55,722,733 Sole
Life Healthcare Inc 450,035 13,612,681 Sole
Vitru Ltd 107,439 6,246,471 Sole
Onesmart Intl Ed Group Ltd 9,668 7,860,000 Sole
Talos Energy Inc 36,368 2,325,337 Sole
Seacor Marine Hldgs Inc 5,063 1,147,989 Sole
SiriusPoint Ltd 1,303 129,408 Sole

Material Changes and Guidance

Material Changes: This filing is a snapshot of holdings as of June 30, 2021. It does not contain comparative data against the prior quarter (March 31, 2021) within this specific text, so material changes in position size cannot be calculated from this document alone.

Guidance and Outlook: Form 13F filings are regulatory disclosures of past holdings and do not contain management commentary, forward-looking guidance, risk factors, or contingency plans. The filing text does not provide a clear value for these items.

Investor Verification Checklist

  • Portfolio Completeness: Verify if this table represents the entire equity portfolio or a subset, as Form 13F filings can be split across multiple schedules.
  • Position Aggregation: Note that Atotech Ltd appears twice; confirm if these represent separate accounts or distinct tranches of the same investment.
  • Valuation Timing: Confirm that the reported values reflect market prices as of the last trading day of the quarter (June 30, 2021).
  • Discretionary Authority: Verify the "DFND" (Discretionary) status for all positions to understand the manager's control level.